5-03-2025, 21:00

Pow.Bio Unveils State-of-the-Art Facility in Alameda, Expanding Biomanufacturing Capabilities to Support Demand for Continuous Fermentation

Notified -
Globe Newswire5-03-2025, 21:00
7-01-2025, 20:00

Hummingbird Bioscience Licenses Novel Antibodies to Immunome

Notified -
Globe Newswire7-01-2025, 20:00
9-12-2024, 19:03

AiViva Biopharma Receives FDA Clearance to Administer AIV001 in Facial Skin by Intradermal Injection for Nonmelanoma Skin Cancer

Notified -
Globe Newswire9-12-2024, 19:03
7-08-2024, 20:00

Winners in First Annual Stevie® Awards for Technology Excellence Announced
Globe Newswire7-08-2024, 20:00
3-07-2024, 15:30

Olon Group Announces the Acquisition of GTP Bioways Group
Globe Newswire3-07-2024, 15:30
20-05-2024, 07:00

Amplexd Therapeutics, Innovating to Revolutionize the Future of Non-Invasive HPV-induced Cervical Intraepithelial Neoplasia (CIN) Treatments for the Prevention of Cervical Cancer: Developed by Women for Women

[img]http://phpstack-1214942-4313335.cloudwaysapps.com/api/ImageRender/DownloadFile?resourceId=f83bbfc7-6e0b-45d2-9685-2
Globe Newswire20-05-2024, 07:00
13-05-2024, 16:30

Hummingbird Bioscience Presents New Preclinical Data Highlighting Next-Generation Antibody-Drug Conjugate Capabilities at PEGS Boston 2024
Globe Newswire13-05-2024, 16:30
11-12-2023, 20:00

AiViva Biopharma Completes Phase 1/2 Clinical Trial of AIV001 Administration in Patients with Nonmelanoma Skin Cancer
Globe Newswire11-12-2023, 20:00
31-10-2023, 18:00

Cambrium Secures €8 Million in Seed Funding to Commercialize New Class of Performance Molecules
Globe Newswire31-10-2023, 18:00
18-09-2023, 17:00

AiViva Biopharma Appoints Lester J. Kaplan, PhD to the Board of Directors
Globe Newswire18-09-2023, 17:00
6-06-2023, 14:00

Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023
Globe Newswire6-06-2023, 14:00
23-05-2023, 20:00

Telesis Bio to Present at SynBioBeta 2023
Globe Newswire23-05-2023, 20:00